Trials / Completed
CompletedNCT02206945
Neurofeedback for Obsessive-Compulsive Disorder (OCD)
Neurofeedback of Activity in the Orbitofrontal Cortex for OCD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to train patients with obsessive-compulsive disorder to control a region of their brain that has been associated with their symptoms. Patients in the experimental group will be given direct feedback regarding activity in this brain area while they are undergoing functional magnetic resonance imaging (fMRI) scanning, and will try to learn to control activity in the region during these feedback sessions. A separate group of patients will be given a control form of feedback that we do not believe can have clinical benefits. Our primary hypothesis is that the neurofeedback training will reduce OCD symptoms more than the control feedback.
Detailed description
Original study design recruiting controls who were matched to the experimental group was changed to a randomized design prior to enrollment of the first participant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | neurofeedback | Subject provided with feedback of activity in target brain area in the form of a line graph. Cued to try to make the line go up at certain times and down at other times. |
| BEHAVIORAL | control feedback | Subject provided with a control/placebo type of feedback in the form of a line graph. Cued to try to make the line go up at certain times and down at other times. |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2021-11-01
- Completion
- 2021-11-01
- First posted
- 2014-08-01
- Last updated
- 2022-02-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02206945. Inclusion in this directory is not an endorsement.